IndraLab

Statements


Hsp90 inhibitor activates KCNH2. 3 / 3
| 3

reach
"It has previously been demonstrated that the Hsp90 inhibitor, geldanamycin, inhibits hERG trafficking, presumably through an Hsp90 dependent mechanism."

reach
"In our previous study, we found that geldanamycin, an Hsp90 inhibitor, abolished the kinase dependent increase in HERG abundance."

reach
"The specific Hsp90 inhibitor geldanamycin prevents maturation and increases proteasomal degradation of hERG WT, while reducing hERG currents in heterologous expression systems."